XMAD
NTH
Market cap114mUSD
Apr 09, Last price
1.70EUR
1D
-2.30%
1Q
-2.86%
Jan 2017
-64.21%
IPO
-65.93%
Name
Naturhouse Health SA
Chart & Performance
Profile
Naturhouse Health, S.A. operates in the nutrition and weight management industry in Spain, Italy, France, Poland, and internationally. The company sells food supplements that are made from natural extracts to facilitate the consumption of various nutrients; and foods and drinks, such as diet products for breakfast, snacks, and meal substitutes. It also offers cosmetics and body care products, including beauty products related to skincare during the slimming process comprising cellulite, firming products, etc.; and anti-ageing products. As of December 31, 2020, it operated through a network of 1,788 centers in 28 countries. The company sells its products through directly operated and franchised Naturhouse centers. The company was formerly known as Housediet, S.L.U. The company was founded in 1991 and is based in Madrid, Spain.
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | |||||||||
Revenues | 50,407 -3.81% | 52,403 -9.01% | |||||||
Cost of revenue | 16,573 | 25,089 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | 33,834 | 27,314 | |||||||
NOPBT Margin | 67.12% | 52.12% | |||||||
Operating Taxes | 4,168 | 3,484 | |||||||
Tax Rate | 12.32% | 12.76% | |||||||
NOPAT | 29,666 | 23,830 | |||||||
Net income | 11,293 17.31% | 9,627 -27.95% | |||||||
Dividends | (6,000) | (18,000) | |||||||
Dividend yield | 6.18% | 19.00% | |||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
Debt | |||||||||
Debt current | 1,515 | 1,199 | |||||||
Long-term debt | 6,697 | 5,335 | |||||||
Deferred revenue | |||||||||
Other long-term liabilities | 1,641 | 4,189 | |||||||
Net debt | (29,174) | (16,207) | |||||||
Cash flow | |||||||||
Cash from operating activities | 20,950 | 7,097 | |||||||
CAPEX | (570) | (964) | |||||||
Cash from investing activities | (459) | (5,218) | |||||||
Cash from financing activities | (7,695) | (16,985) | |||||||
FCF | 35,077 | 20,284 | |||||||
Balance | |||||||||
Cash | 27,098 | 14,775 | |||||||
Long term investments | 10,288 | 7,966 | |||||||
Excess cash | 34,866 | 20,121 | |||||||
Stockholders' equity | 28,626 | 35,482 | |||||||
Invested Capital | 9,881 | 13,609 | |||||||
ROIC | 252.58% | 220.58% | |||||||
ROCE | 87.24% | 80.25% | |||||||
EV | |||||||||
Common stock shares outstanding | 59,949 | 59,949 | |||||||
Price | 1.62 2.53% | 1.58 -18.13% | |||||||
Market cap | 97,118 2.53% | 94,720 -18.13% | |||||||
EV | 67,950 | 78,565 | |||||||
EBITDA | 36,097 | 29,612 | |||||||
EV/EBITDA | 1.88 | 2.65 | |||||||
Interest | 616 | 206 | |||||||
Interest/NOPBT | 1.82% | 0.75% |